Lack of insight in schizophrenia - Impact on treatment adherence

被引:145
作者
Buckley, Peter F.
Wirshing, Donna A.
Bhushan, Prameet
Pierre, Joseph M.
Resnick, Seth A.
Wirshing, William C.
机构
[1] Med Coll Georgia, Dept Psychiat, Augusta, GA 30912 USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
关键词
ACTING INJECTABLE RISPERIDONE; MEDICATION ADHERENCE; ANTIPSYCHOTIC-DRUGS; NEUROPSYCHOLOGICAL FUNCTION; SCHIZOAFFECTIVE DISORDER; COMPLIANCE THERAPY; PSYCHOTIC ILLNESS; 1ST EPISODE; UNAWARENESS; DEPRESSION;
D O I
10.2165/00023210-200721020-00004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
People with schizophrenia commonly lack insight, that is, they are unaware of their illness and the consequences thereof. One of the most important consequences of lack of insight is a failure to recognise the need for treatment, leading to treatment nonadherence. With several scales that now enable objective measurement of insight, it is possible to examine correlates of insight change, including course of illness and treatment adherence. Specific interventions, both pharmacological and psychotherapeutic, have been developed to enhance illness insight and treatment adherence. The extent to which second-generation antipsychotic medications, including a recently released long-acting formulation, improve insight and/or enhance treatment adherence remains to be determined.
引用
收藏
页码:129 / 141
页数:13
相关论文
共 91 条
[1]   Systematic meta-review of depot antipsychotic drugs for people with schizophrenia [J].
Adams, CE ;
Fenton, MKP ;
Quraishi, S ;
David, AS .
BRITISH JOURNAL OF PSYCHIATRY, 2001, 179 :290-299
[2]  
AGUGLIA E, 2002, BIOL PSYCHIAT, V26, P229
[3]   Insight in psychosis and neuropsychological function - Meta-analysis [J].
Aleman, Andre ;
Agrawal, Niruj ;
Morgan, Kevin D. ;
David, Anthony S. .
BRITISH JOURNAL OF PSYCHIATRY, 2006, 189 :204-212
[4]  
Amador X., 2000, I AM NOT SICK I DONT
[5]  
AMADOR XF, 1994, ARCH GEN PSYCHIAT, V51, P826
[6]  
Amador XF, 1996, AM J PSYCHIAT, V153, P1185
[7]  
AMADOR XF, 2004, INSIGHT SCHIZOPHRENI
[8]   Patients subjective experiences on antipsychotic medications: Implications for outcome and quality of life [J].
Awad, AG ;
Hogan, TP ;
Voruganti, LNP ;
Heslegrave, RJ .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 :123-132
[9]   DEPRESSION, DEMORALIZATION AND CONTROL OVER PSYCHOTIC ILLNESS - A COMPARISON OF DEPRESSED AND NONDEPRESSED PATIENTS WITH A CHRONIC PSYCHOSIS [J].
BIRCHWOOD, M ;
MASON, R ;
MACMILLAN, F ;
HEALY, J .
PSYCHOLOGICAL MEDICINE, 1993, 23 (02) :387-395
[10]   Cognitive approach to depression and suicidal thinking in psychosis I. Ontogeny of post-psychotic depression [J].
Birchwood, M ;
Iqbal, Z ;
Chadwick, P ;
Trower, P .
BRITISH JOURNAL OF PSYCHIATRY, 2000, 177 :516-521